Do ABO blood group antigens hamper the therapeutic efficacy of mesenchymal stromal cells?

Por Guido Moll, Annika Hult, Lena von Bahr, Jessica J Alm, Nina Heldring, Osama A Hamad, Lillemor Stenbeck-Funke, Stella Larsson, Yuji Teramura, Helene Roelofs, Bo Nilsson, Willem E Fibbe, Martin L Olsson, Katarina Le Blanc
Publicado em 2014-01-01